Advertisement

Picture Berlin Partner Bionnale 2021 Digital Event 650x80px

News > All

Total search results: 4610 | Ordered by Source (ascending)
1 2 3 ... 45 46 47  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
10x Genomics Inc.. (2/24/21). "Press Release: 10x Genomics Showcases Next Wave of Innovations at First Ever Xperience Event. Acquires Tetramer Shop, Reveals Details on Upcoming Products". Pleasanton, CA. 2021-02-24
3B Pharmaceuticals GmbH. (11/20/18). "Press Release: Ipsen and 3BP Announce First Patient Dosed in Phase I/II Study for First-in-class Radionuclide (IPN01087)". Paris. 2018-11-20
4basebio AG. (7/28/20). "Press Release: 4basebio Informs about Takeover Bid by Sparta AG". Heidelberg & Cambridge. 2020-07-28
4D Molecular Therapeutics. (4/30/18). "Press Release: 4DMT and Roche Expand Ophthalmology Partnership to Develop and Commercialize Multiple AAV Gene Therapy Products". Emeryville, CA. 2018-04-30
4SC AG. (10/10/17). "Press Release: Resminostat Demonstrates Potential to Significantly Alleviate Itching in CTCL Patients". Planegg-Martinsried. 2017-10-10
4SC AG. (10/21/16). "Press Release: Dr Daniel Vitt to Step Down as CDO/CSO and from the Management Board at the End of 2016". Planegg-Martinsried. 2016-10-21
4SC AG. (10/26/17). "Press Release: 4SC Provides Q3 and 9M 2017 Update". Planegg-Martinsried. 2017-10-26
4SC AG. (11/12/19). "Press Release: 4SC AG Secures circa EUR 22.4 Million from a Capital Increase [Not for release in US, Australia, Canada, et al.]". Planegg-Martinsried. 2019-11-12
4SC AG. (11/25/20). "Press Release: 4SC AG Resolves to Issue New Shares with Expected Proceeds of approx. EUR 7.5 Million (ad hoc) [not for US, AU, CA, JP, ZA, et al.]". Planegg-Martinsried. 2020-11-25
4SC AG. (2/1/18). "Press Release: Positive DSMB Safety Review of 4SC’s Pivotal RESMAIN Study of Resminostat in CTCL". Planegg-Martinsried. 2018-02-01
4SC AG. (2/6/17). "Press Release: 4SC AG to Present at the 19th Annual BIO CEO & Investor Conference 2017". Planegg-Martinsried. 2017-02-06
4SC AG. (2/6/19). "Press Release: First Patient Enrolled in Phase II Study EMERGE of Domatinostat (4SC-202) in Gastrointestinal Cancer". Planegg-Martinsried. 2019-02-06
4SC AG. (3/20/19). "Press Release: 4SC AG Provides Results for Financial Year 2018 and Outlook". Planegg-Martinsried. 2019-03-20
4SC AG. (3/21/18). "Press Release: 4SC AG Announces Results for Financial Year 2017". Planegg-Martinsried. 2018-03-21
4SC AG. (3/27/18). "Press Release: Yakult Honsha Joins 4SC’s Pivotal RESMAIN Study of Resminostat in CTCL – 4SC Receives Milestone Payment". Planegg-Martinsried. 2018-03-27
4SC AG. (4/11/18). "Press Release: Yakult Honsha Recruits First Japanese Patient in 4SC’s Pivotal RESMAIN Study of Resminostat in CTCL". Planegg-Martinsried. 2018-04-11
4SC AG. (4/17/18). "Press Release: 4SC at AACR – Broadened Clinical Options for 4SC-202". Planegg-Martinsried. 2018-04-17
4SC AG. (4/19/18). "Press Release: Phase II Study of 4SC’s Resminostat in Biliary Tract Cancer in Japan Is Initiated". Planegg-Martinsried. 2018-04-19
4SC AG. (4/29/16). "Press Release: 4SC Sells Operations of Its Discovery Division [Ad hoc announcement according to $ 15 WpHG]". Planegg-Martinsried. 2016-04-29
4SC AG. (5/27/16). "Press Release: 4SC Provides Headline Results from Yakult Honsha’s Phase II Trial of Resminostat in Combination with Sorafenib as First Line Therapy in Liver Cancer (Ad hoc announcement according to § 15 WpHG)". Planegg-Martinsried. 2016-05-27
4SC AG. (5/31/16). "Press Release: 4SC Enters into Licensing and Development Partnership with Link Health for the Cancer Compound 4SC-205 in China". Planegg-Martinsried. 2016-05-31
4SC AG. (6/28/19). "Press Release: 4SC AG Secures EUR 11 Million from Capital Increase [Ad hoc, not for US, AU, CA, JP, ZA, et al.]". Planegg-Martinsried. 2019-06-28
4SC AG. (7/18/17). "Press Release: 4SC Licenses Kv1.3 Inhibitors to Maruho. Maruho to Receive Exclusive Worldwide License on 4SC’s Preclinical Inhibitors of the Kv1.3 Ion Channel". Planegg-Martinsried. 2017-07-18
4SC AG. (7/20/16). "Press Release: 4SC Forms International Scientific Expert Panel". Planegg-Martinsried. 2016-07-20
4SC AG. (7/6/17). "Press Release: 4SC AG Secures EUR 41 Million from Successful Capital Increase [Not for US, AU, CA, JP or ZA]". Planegg-Martinsried. 2017-07-06
4SC AG. (8/1/17). "Press Release: 4SC AG Was Granted a Fundamental Composition of Matter Patent for 4SC-208 for the US". Planegg-Martinsried. 2017-08-01
4SC AG. (8/11/16). "Press Release: 4SC Provides Operational and Financial Update for Q2 and 6M 2016". Planegg-Martinsried. 2016-08-11
4SC AG. (8/9/18). "Press Release: 4SC Provides Q2 and H1 2018 Update". Planegg-Martinsried. 2018-08-09
4SC AG. (9/11/20). "Press Release: 4SC and Maruho Discontinue Collaboration for Development of 4SC’s Kv1.3 Inhibitors". Planegg-Martinsried. 2020-09-11
4SC AG. (9/20/18). "Press Release: Domatinostat Plus Chemotherapy – Overcoming Drug Resistance". Planegg-Martinsried. 2018-09-20
4SC AG. (9/21/16). "Press Release: Dr Jason Loveridge Appointed New CEO of 4SC". Planegg-Martinsried. 2016-09-21
4Teen4 Pharmaceuticals GmbH. (12/5/19). "Press Release: Biotech Startup 4Teen4 Pharmaceuticals Closes EUR 7 Million Series A Financing". Hennigsdorf. 2019-12-05
908 Devices, Inc.. (6/2/16). "Press Release: Thermo Fisher Scientific and 908 Devices to Demonstrate Innovative Separation Technology with Industry-Leading Orbitrap Mass Spectrometers at ASMS 2016". 2016-06-02
908 Devices, Inc.. (6/3/19). "Press Release: 908 Devices Broadens the ZipChip Platform, Brings New Capability to Biotherapeutics Researchers". Boston, MA. 2019-06-03
908 Devices, Inc.. (7/25/19). "Press Release: 908 Devices Poised to Modernize Upstream Bioprocess Analytics with a Grant from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)". Boston, MA. 2019-07-25
Aadi Bioscience, Inc.. (5/8/17). "Press Release: Aadi Bioscience Closes $23 Million in Series A Funding". Pacific Palisades, CA. 2017-05-08
AB Sciex (d/b/a Sciex). (12/18/17). "Press Release: Sciex and NofaLab Collaboration Delivers Robust and Sensitive Method for Detecting Multiple Pesticides in a Single Run". Warrington, UK. 2017-12-18
AB Sciex (d/b/a Sciex). (3/22/17). "Press Release: Sciex Presents Novel QTOF Mass Spectrometry System for Simpler and Faster Biotherapeutics Characterisation". Darmstadt. 2017-03-22
AB Sciex (d/b/a Sciex). (4/10/18). "Press Release: Sciex Launches the Citrine Triple Quad MS/MS Systems in Europe, Bringing Maximal Speed and Sensitivity to Clinical Diagnostics Testing". Darmstadt. 2018-04-10
AB Sciex (d/b/a Sciex). (7/27/17). "Press Release: Sciex Equipment Is Now Available Through a Wide Range of Flexible Financing Packages via Evosciences". Warrington. 2017-07-27
AB Sciex (d/b/a Sciex). (8/25/16). "Press Release: Sciex to Introduce Benchtop High Resolution Mass Spec for Forensic Toxicology Analysis at TIAFT 2016 Meeting in Brisbane, Australia, Aug 28 – Sep 1, 2016". Singapore. 2016-08-25
AB Sciex (d/b/a Sciex). (9/15/17). "Press Release: Sciex Announces the Appointment of Inese Lowenstein as President. Former President Jean-Paul Mangeolle to Retire". Framingham, MA. 2017-09-15
AB Sciex (d/b/a Sciex). (9/8/17). "Press Release: Sciex Launches the Topaz LC-MS/MS System for Clinical Diagnostics in Europe". Warrington, UK. 2017-09-08
ABAC Therapeutics. (2/15/18). "Press Release: ABAC Therapeutics Announces €16 Million Series A to Develop Therapeutic Solutions to Fight Antibiotic-resistant Bacteria". Barcelona. 2018-02-15
Abalos Therapeutics GmbH. (10/15/19). "Press Release: Abalos Therapeutics Launches with €12M Series A Round to Develop Novel Immuno-Virotherapies Against Cancer". Essen. 2019-10-15
AbbVie Inc.. (1/25/19). "Press Release: AbbVie Reports Full-Year and Fourth-Quarter 2018 Financial Results". North Chicago, IL. 2019-01-25
AbbVie Inc.. (6/25/19). "Press Release: AbbVie to Acquire Allergan in Transformative Move for Both Companies". 2019-06-25
Abcam plc. (7/2/18). "Press Release: Abcam Merck Collaboration Produces New PD-L1 Antibody for Immuno-Oncology Research". Cambridge. 2018-07-02
AbCellera Biologics, Inc.. (2/14/19). "Press Release: AbCellera Announces Multi-Target Partnership Agreement with a Top 5 Global Pharma". Vancouver, BC. 2019-02-14
Abeona Therapeutics Inc.. (4/2/18). "Press Release: Abeona Therapeutics Appoints Carsten Thiel, Ph.D., as Chief Executive Officer". New York, NY & Cleveland, OH. 2018-04-02
Abingworth LLP. (2/3/21). "Press Release: Abingworth Raises $465m for New Life Sciences Fund Abingworth Bioventures 8". London. 2021-02-03
Abionic S.A.. (3/28/18). "Press Release: Abionic Successfully Raises CHF20 Million in Series C Financing". Lausanne. 2018-03-28
Abionic S.A.. (9/13/19). "Press Release: International Pivotal Study Successfully Demonstrates Diagnosis of Sepsis within 5 Minutes – 24 Hours Earlier Compared with Current Standard-of-Care". Lausanne. 2019-09-13
Abionic S.A.. (9/5/19). "Press Release: Abionic Signs Agreement to Optimize Asthma Management in the U.S. through Innovative Rapid Point-of-Care Tests". Lausanne. 2019-09-05
Abivax S.A.. (11/20/17). "Press Release: Abivax Enrolls First Ulcerative Colitis Patient in New ABX464 Proof-of-Concept Clinical Trial". Paris. 2017-11-20
Abivax S.A.. (3/14/19). "Press Release: Abivax 2018 Financial Results and Operations Update". Paris. 2019-03-14
Abivax S.A.. (6/25/18). "Press Release: Abivax Appoints Ian McGowan as Scientific Advisory Board Chair and Juergen Rockstroh as a New Member". Paris. 2018-06-25
Abivax S.A.. (9/20/17). "Press Release: Abivax First-half 2017 Financial Results and Update". Paris. 2017-09-20
Abivax S.A.. (9/4/18). "Press Release: Abivax Reports Impressive Results in Clinical Phase 2a Trial of ABX464 as an Oral Treatment for Ulcerative Colitis Patients". Paris. 2018-09-04
Ablynx N.V.. (1/24/18). "Press Release: Ablynx Appoints Dr Robert Friesen as Chief Scientific Officer". Ghent. 2018-01-24
Ablynx N.V.. (11/16/17). "Press Release: Ablynx Announces Results for the First Nine Months of 2017 and a Year-to-Date Business Update". Ghent. 2017-11-16
Ablynx N.V.. (2/7/18). "Press Release: Ablynx Announces Board Changes". Ghent. 2018-02-07
Ablynx N.V.. (4/21/16). "Press Release: Ablynx to Receive an €8 Million Milestone as Boehringer Ingelheim Starts a Phase I Study with an anti-CX3CR1 Nanobody". Ghent & Ingelheim. 2016-04-21
Ablynx N.V.. (4/29/16). "Press Release: Ablynx Announces Milestone in Drug Discovery Collaboration". Ghent. 2016-04-29
Ablynx N.V.. (5/22/17). "Press Release: Novel Nanobody to Start Clinical Development in Osteoarthritis. Ablynx to Receive €15 Million Milestone Payment". Ghent. 2017-05-22
Ablynx N.V.. (6/13/17). "Press Release: Ablynx Appoints Markus Ewert as Chief Business Officer". Ghent. 2017-06-13
AC Immune S.A.. (1/30/19). "Press Release: AC Immune Reports Discontinuation of Phase III CREAD 1 and 2 Studies of Crenezumab in Alzheimer’s Disease". Lausanne. 2019-01-30
AC Immune S.A.. (11/23/16). "Press Release: AC Immune Appoints Experienced Life Science Professional as New Chief Financial Officer". Lausanne. 2016-11-23
AC Immune S.A.. (12/12/18). "Press Release: AC Immune and Lilly Announce License and Collaboration Agreement". Lausanne & Indianapolis, IN. 2018-12-12
AC Immune S.A.. (12/19/18). "Press Release: AC Immune and WuXi Biologics to Establish an Exclusive Strategic Partnership". Lausanne & Shanghai. 2018-12-19
AC Immune S.A.. (12/7/18). "Press Release: In Memoriam – Dr. Andreas Muhs CSO, Scientific Leader and Friend Has Passed Away". Lausanne. 2018-12-07
AC Immune S.A.. (3/17/17). "Press Release: AC Immune Reports Full Year 2016 Financial Results and R&D Update". Lausanne. 2017-03-17
AC Immune S.A.. (3/21/19). "Press Release: AC Immune Reports Full-Year 2018 Financial Results and Provides Business Update". Lausanne. 2019-03-21
AC Immune S.A.. (3/23/17). "Press Release: AC Immune Provides Twelve Update on Its Pipeline". Lausanne. 2017-03-23
AC Immune S.A.. (3/23/20). "Press Release: AC Immune Receives Second Milestone and New Milestone to Increase the Potential Deal Value of Lilly Morphomer Tau Partnership". Lausanne. 2020-03-23
AC Immune S.A.. (5/9/16). "Press Release: AC Immune Raises USD 43.5 Million (CHF 42.7 Million) in Financing Round E". Lausanne. 2016-05-09
AC Immune S.A.. (7/7/16). "Press Release: AC Immune to Receive Milestone Payment for Anti-Tau Antibody Moving into Phase 1 Trial for Alzheimer’s Disease". Lausanne. 2016-07-07
AC Immune S.A.. (8/12/19). "Press Release: AC Immune Announces Research Collaboration with University of Pennsylvania Focusing on Pathogenic Protein TDP-43 in Neurodegenerative Diseases". Lausanne. 2019-08-12
AC Immune S.A.. (8/22/17). "Press Release: AC Immune Discovers Next-generation Antibodies Focused on Neurodegenerative Diseases". Lausanne. 2017-08-22
AC Immune S.A.. (8/5/20). "Press Release: AC Immune Reports Q2 2020 Financial Results and Provides Business Update". Lausanne. 2020-08-05
AC Immune S.A.. (8/9/17). "Press Release: AC Immune Reports Second Quarter 2017 Financial Results". Lausanne. 2017-08-09
AC Immune S.A.. (9/13/16). "Press Release: AC Immune Commences Proposed Initial Public Offering of Common Shares". Lausanne. 2016-09-13
AC Immune S.A.. (9/17/19). "Press Release: AC Immune Receives Milestone Payment in Connection with Initiation of a Phase 2 Trial of Tau PET Tracer PI-2620". Lausanne. 2019-09-17
AC Immune S.A.. (9/20/19). "Press Release: AC Immune Receives First Milestone Payment from Lilly in Small Molecule Tau Morphomer Program". Lausanne. 2019-09-20
AC Immune S.A.. (9/23/16). "Press Release: AC Immune Announces Pricing of Upsized Initial Public Offering". Lausanne. 2016-09-23
AC Immune S.A.. (9/23/16). "Press Release: Switzerland’s AC Immune Opens for Trading on Nasdaq". Lausanne. 2016-09-23
AC Immune S.A.. (9/4/19). "Press Release: AC Immune Awarded Michael J. Fox Foundation Grant to Accelerate Development of Parkinson’s Disease Diagnostic Imaging Agent". Lausanne. 2019-09-04
Acesion Pharma ApS. (11/15/16). "Press Release: Acesion Pharma Recruits an Experienced Life Science Chief Financial Officer". Copenhagen. 2016-11-15
Acousia Therapeutics GmbH. (12/14/16). "Press Release: Acousia Therapeutics Receives EUR 2.5 Million to Develop Innovative Therapy to Treat and Prevent Sensorineural Hearing Loss". Tübingen. 2016-12-14
Acousia Therapeutics GmbH. (5/14/18). "Press Release: Acousia Therapeutics Announces €10 Million Series B Financing to Advance its Hearing Loss Portfolio". Tübingen. 2018-05-14
ActeaVentures GmbH. (2/21/17). "Press Release: ActeaVentures Successfully Assisted Neovacs in Partnering IFN-K for Lupus to BioSense Global for the Chinese Market". Karlsruhe. 2017-02-21
Actelion Ltd.. (1/23/17). "Press Release: Actelion Announces Results of the MAESTRO Study with Macitentan in Patients with Pulmonary Arterial Hypertension Due to Eisenmenger Syndrome". Allschwil. 2017-01-23
Actelion Ltd.. (1/26/17). "Press Release: Johnson & Johnson to Acquire Actelion for $30 Billion with Spin-out of New R&D Company". New Brunswick, NJ & Allschwil. 2017-01-26
Actelion Ltd.. (11/25/16). "Press Release: Actelion Statement [on Possible Transaction with Johnson & Johnson]". Allschwil. 2016-11-25
Actelion Ltd.. (11/3/16). "Press Release: Actelion Obtains an Option to In-license Vamorolone from ReveraGen". Allschwil & Rockville, MD. 2016-11-03
Actelion Ltd.. (12/21/16). "Press Release: Actelion and Johnson & Johnson Enter into Exclusive Discussions". Allschwil. 2016-12-21
Actelion Ltd.. (5/17/16). "Press Release: Actelion Is Granted Marketing Authorization for Uptravi (selexipag) in Pulmonary Arterial Hypertension by the European Commission". Allschwil. 2016-05-17
Actelion Ltd.. (6/14/17). "Press Release: Actelion Announces Changes to Its Executive Team upon Completion of the Transaction with Johnson & Johnson". Allschwil. 2017-06-14
Actelion Ltd.. (6/15/16). "Press Release: Actelion Announces Commercial Availability of Uptravi (selexipag) in Germany". Freiburg & Allschwil. 2016-06-15
Actelion Ltd.. (6/16/17). "Press Release: Johnson & Johnson Completes Acquisition of Actelion". Allschwil. 2017-06-16
1 2 3 ... 45 46 47  next pagenext page



Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [iito] Made Without Love 650x80px

» top